AlphaYouDK
Insider selling
David Krempa sold $229K of Eton Pharmaceuticals, Inc. (ETON) stock
David Krempa, Chief Business Officer of Eton Pharmaceuticals, Inc. (ETON), sold 4,166 shares of ETON stock worth $229K, per an SEC Form 4 filed Oct 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Oct 6, 2026.
ETON has moved +0.0% since the trade date, from $54.77 to $54.77 (Oct 6, 2026 close).
- Traded
- Oct 6, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 0 days
- Price since
- +0.0%
- Role
- Chief Business Officer
- Source
- SEC Form 4
More ETON insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.